Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.04 USD | +1.32% | -0.38% | +12.61% |
Financials (USD)
Sales 2024 * | 998M | Sales 2025 * | 1.03B | Capitalization | 528M |
---|---|---|---|---|---|
Net income 2024 * | 15M | Net income 2025 * | 28M | EV / Sales 2024 * | 0.83 x |
Net Debt 2024 * | 301M | Net Debt 2025 * | 297M | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
35.2
x | P/E ratio 2025 * |
18.4
x | Employees | 1,920 |
Yield 2024 * |
3.68% | Yield 2025 * |
3.63% | Free-Float | 49.9% |
Latest transcript on Phibro Animal Health Corporation
1 day | +1.32% | ||
1 week | -0.38% | ||
Current month | +0.85% | ||
1 month | +4.49% | ||
3 months | +15.09% | ||
6 months | +7.68% | ||
Current year | +12.61% |
Managers | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
Glenn David
DFI | Director of Finance/CFO | 52 | Feb. 08 |
Larry Miller
COO | Chief Operating Officer | 60 | 08-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
E. Corcoran
BRD | Director/Board Member | 77 | 08-04-30 |
Carol Wrenn
BRD | Director/Board Member | 63 | 10-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.33% | 27 M€ | -7.00% | - | |
0.32% | 29 M€ | -6.85% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 13.04 | +1.32% | 78,597 |
24-04-17 | 12.87 | -0.92% | 99,784 |
24-04-16 | 12.99 | -1.67% | 139,846 |
24-04-15 | 13.21 | +0.76% | 146,143 |
24-04-12 | 13.11 | +0.15% | 120,894 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.61% | 521M | |
-8.93% | 6.61B | |
+13.00% | 3.36B | |
+3.76% | 3.28B | |
+2.87% | 1.51B | |
-17.92% | 1.33B | |
-7.71% | 1.23B | |
-28.92% | 1.2B | |
-17.76% | 1.09B | |
-3.84% | 1.02B |
- Stock Market
- Equities
- PAHC Stock